Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALBOCICLIB Cause Contraindicated product administered? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Contraindicated product administered have been filed in association with PALBOCICLIB (Ibrance). This represents 0.0% of all adverse event reports for PALBOCICLIB.

8
Reports of Contraindicated product administered with PALBOCICLIB
0.0%
of all PALBOCICLIB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Contraindicated product administered From PALBOCICLIB?

Of the 8 reports, 1 (12.5%) required hospitalization.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does PALBOCICLIB Cause?

Fatigue (15,190) White blood cell count decreased (11,273) Neoplasm progression (10,885) Death (8,410) Nausea (8,189) Neutropenia (6,423) Alopecia (6,201) Diarrhoea (5,635) Asthenia (3,660) Off label use (3,405)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which PALBOCICLIB Alternatives Have Lower Contraindicated product administered Risk?

PALBOCICLIB vs PALIPERIDONE PALBOCICLIB vs PALIVIZUMAB PALBOCICLIB vs PALONOSETRON PALBOCICLIB vs PAMIDRONATE PALBOCICLIB vs PAMIDRONIC ACID

Related Pages

PALBOCICLIB Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered PALBOCICLIB Demographics